Influenza News and Research

Latest Influenza News and Research

SARS-CoV-2 Mpro inhibitors built on rattlesnake venom scaffold

A new study describes the development of new molecules with inhibitory activity against the SARS-CoV-2 viral main protease (Mpro) enzyme, based on rattlesnake venom.

29 Apr 2022

Probenecid shows activity against respiratory syncytial virus

A new study describes the antiviral activity of the approved drug probenecid against respiratory syncytial virus.

29 Apr 2022

Study finds curcumin is a potential therapeutic agent against the Omicron variant of SARS-CoV-2

A recent study demonstrated that the phytochemical curcumin is a potent therapeutic prospect against the SARS-CoV-2 Omicron variant

29 Apr 2022

Review aims to deepen the understanding of the role of natural killer cells in COVID-19

In a recent study published in Biomedicines, researchers explored the utility of natural killer (NK) cells in coronavirus disease 2019 (COVID-19).

28 Apr 2022

Survey identifies maternal attitude towards COVID-19 vaccination during pregnancy

Researchers designed a survey to investigate whether maternal beliefs were associated with COVID-19 vaccine-hesitancy during pregnancy.

27 Apr 2022

Comparative analysis of transcriptional responses across 13 different vaccines

A new study aimed to carry out a comparative analysis of transcriptional responses from 820 healthy young adults across 13 different vaccines.

27 Apr 2022

St. John's wort extract shows potent antiviral activity against SARS-CoV-2 and its variants

Scientists from Germany have recently identified Hypericum perforatum, a widespread herbal plant known as St. John's wort, as a potential antiviral agent against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study is published in the journal Pharmaceuticals.

27 Apr 2022

Canine COVID-19 vaccine could prevent reverse transmission of SARS-CoV-2

The new study, published in the journal Vaccines, reports on an attempt to use the SARS-CoV-2 spike subunit protein to elicit an immune reaction.

26 Apr 2022

Unhealthy air increases the chances of catching COVID-19

A Swedish study published in the journal JAMA Network Open investigates the association between short-term exposure to air pollution and SARS-CoV-2 infection.

26 Apr 2022

As vaccination coverage increases, SARS-CoV-2 genetic diversity decreases

In a recent letter to the editor published in the Journal of Infection, researchers from the Chinese PLA Center for Disease Control and Prevention observed that the genetic diversity of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) could be suppressed by high coverage of vaccination.

25 Apr 2022

Marine resources could be promising drug candidates against SARS-CoV-2 Omicron

A recent review paper, published in the MDPI’s specialized journal COVID, highlights key features of the Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – and examines the potential and roadblocks in using renewable marine resources in the fight against the coronavirus disease 2019 (COVID-19).

24 Apr 2022

Continual genomic surveillance in Africa provides insights into evolving SARS-CoV-2 pandemic

Researchers described how SARS-CoV-2 genomic sequencing efforts in Africa helped identify two of the five SARS-CoV-2 VOCs, and their early analysis.

22 Apr 2022

Study suggests SARS-CoV-2 is undergoing evolutionary changes at the functional RNA level in addition to the amino acid level

Researchers demonstrated SARS-CoV-2 evolution at the transcriptional level.

22 Apr 2022

Influenza News and Research

Latest Influenza News and Research

SARS-CoV-2 Mpro inhibitors built on rattlesnake venom scaffold

Probenecid shows activity against respiratory syncytial virus

Study finds curcumin is a potential therapeutic agent against the Omicron variant of SARS-CoV-2

Review aims to deepen the understanding of the role of natural killer cells in COVID-19

Survey identifies maternal attitude towards COVID-19 vaccination during pregnancy

Comparative analysis of transcriptional responses across 13 different vaccines

St. John's wort extract shows potent antiviral activity against SARS-CoV-2 and its variants

Canine COVID-19 vaccine could prevent reverse transmission of SARS-CoV-2

Unhealthy air increases the chances of catching COVID-19

As vaccination coverage increases, SARS-CoV-2 genetic diversity decreases

Marine resources could be promising drug candidates against SARS-CoV-2 Omicron

Continual genomic surveillance in Africa provides insights into evolving SARS-CoV-2 pandemic

Study suggests SARS-CoV-2 is undergoing evolutionary changes at the functional RNA level in addition to the amino acid level

Rhinovirus the main virus co-circulating with SARS-CoV-2 in children

New approach successfully differentiates between antibodies against influenza and SARS-CoV-2

Study evaluates SARS-CoV-2 whole genome data from patients and staff in the VA Northeast Ohio Healthcare System

Intranasal nanoparticle STING agonist with immunoantiviral activity against SARS-CoV-2 variants

Wearables can identify changes in physiological systems during COVID-19 disease progression

Researchers investigate COVID-19 data with logistic regression model training

Better ventilation can prevent covid spread. But are companies paying attention?

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Influenza News and Research

Latest Influenza News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in